Measuring Serum Vedolizumab and Vedolizumab Antibodies: Comparison of Commercial Assays with the Vedolizumab Clinical Development Assay

por Vande Casteele, Niels, Yang, Lili, Dobler, Iwona, Agboton, Christian, McRorie Osborn, Teresa, Suri, Ajit, Lindner, Dirk, Smithson, Glennda M.
Publicado 2023

Efficacy and Safety of Subcutaneous Vedolizumab in Patients With Moderately to Severely Active Crohn’s Disease: Results From the VISIBLE 2 Randomised Trial

por Vermeire, Séverine, D’Haens, Geert, Baert, Filip, Danese, Silvio, Kobayashi, Taku, Loftus, Edward V, Bhatia, Siddharth, Agboton, Christian, Rosario, Maria, Chen, Chunlin, Zhang, Wenwen, Kisfalvi, Krisztina, Sandborn, William J
Publicado 2021

Attributes influencing parental decision-making to receive the Tdap vaccine to reduce the risk of pertussis transmission to their newborn – outcome of a cross-sectional conjoint ex...

por Ledent, Edouard, Gabutti, Giovanni, de Bekker-Grob, Esther W., Alcázar Zambrano, Juan Luis, Campins Martí, Magda, Del Hierro Gurruchaga, María Teresa, Fernández Cruz, María José, Ferrera, Giuseppe, Fortunato, Francesca, Torchio, Pierfederico, Zoppi, Giorgio, Agboton, Christian, Kandeil, Walid, Marchetti, Federico
Publicado 2019